Brianna S Cagle

Title: Brianna S Cagle: Innovator in Fibroblast Activation Protein Targeting Peptides

Introduction

Brianna S Cagle is a notable inventor based in Coralville, IA (US). She has made significant contributions to the field of biomedical research, particularly in the development of peptides targeting fibroblast activation protein alpha (FAP). Her innovative work has the potential to impact therapeutic strategies in various medical conditions.

Latest Patents

Brianna holds a patent for "Fibroblast activation protein targeting peptides." The invention relates to a specific structure of peptides, denoted as A-[Z-AA-AA-AA-AA-AA-AA-AA-Z]-B. In this structure, A represents the N-terminal, B represents the C-terminal, and each Z and AA corresponds to residues of amino acids. The peptides can be either linear or cyclized, showcasing her innovative approach to peptide design.

Career Highlights

Brianna is currently associated with Perspective Therapeutics, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and excellence in the field of therapeutic peptides.

Collaborations

Brianna collaborates with esteemed colleagues, including Michael K Schultz and Mengshi Li, who contribute to her research endeavors and enhance the collaborative spirit within her team.

Conclusion

Brianna S Cagle is a pioneering inventor whose work in fibroblast activation protein targeting peptides exemplifies the intersection of innovation and therapeutic development. Her contributions are poised to make a lasting impact in the biomedical field.